Comparative teratogenicity analysis of valnoctamide, risperidone, and olanzapine in mice

Objectives Based on the recent findings from animal studies, it has been proposed that the therapeutic use of valnoctamide, an anxiolytic drug developed in the early 1960s, be extended to treat other neurological disorders such as epilepsy and bipolar disease. Given the scarcity of adequate data on its prenatal toxicity, a comparative teratogenicity study of valnoctamide and two of the most commonly used drugs to treat bipolar disorder, risperidone and olanzapine, was carried out in a mouse model system. Methods Pregnant dams were treated with the aforementioned three drugs at the dose levels calculated as an equal proportion of the respective LD 50 values of these drugs. The main reproductive indices examined included the numbers of implantations and resorptions, viable and dead fetuses, and fetal gross, visceral and skeletal abnormalities. Results The outcomes of the present study indicated that olanzapine was the most teratogenic of the three drugs, inducing maternal‐, embryo‐, and fetotoxicity. Risperidone also exerted a significant prenatal toxicity, but its adverse effect was less pronounced than that induced by olanzapine. Valnoctamide did not show any teratogenic effect, even when used in relatively higher dosages than olanzapine and risperidone. The observed increased skeletal abnormalities in one of the valnoctamide treatment groups were nonspecific and, as such, signaled a modest developmental delay rather than an indication that the compound could induce structural malformations. Conclusions Under our experimental conditions, valnoctamide demonstrated the lowest prenatal toxicity of the three tested drugs.